title: [Use of proton pump inhibitors and the risk of chronic kidney disease].
authors.affiliation: Atención Primaria, Centro de Salud Casas Ibáñez, Albacete, España; Grado de Medicina, Universidad Católica San Antonio de Murcia (UCAM), Murcia, España; Grupo HTA de SEMERGEN. Electronic address: jadivison@telefonica.net.
authors.forename: J A
authors.initials: JA
authors.lastname: Divisón Garrote
authors.affiliation: Servicio de Cardiología, Hospital La Paz, Madrid, España; Grupo HTA de SEMERGEN.
authors.forename: C
authors.initials: C
authors.lastname: Escobar Cervantes
mesh_terms: D000368:Aged; D005260:Female; D005919:Glomerular Filtration Rate; D006635:Histamine H2 Antagonists / Q000008:administration & dosage; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D054328:Proton Pump Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D051436:Renal Insufficiency, Chronic / Q000453:epidemiology / Q000209:etiology*; D012306:Risk; D012307:Risk Factors
chemical_list: D006635:Histamine H2 Antagonists; D054328:Proton Pump Inhibitors